跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
WINRHO SDF - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
WINRHO SDF
Authorized
STANDARD
WINRHO SDF
Aptevo BioTherapeutics LLC
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
55eb2b1a8fe567a7
Company
Aptevo BioTherapeutics LLC
Type
Standard
Approval Details
Approval Id
55eb2b1a8fe567a7
Drug Approval Canada Name
WINRHO SDF
Product Name
WINRHO SDF
Status
Cancelled Post Market
Status Date
2016-07-15
Original Market Date
1996-08-28
Drug Class
Human
Dosage Form
Kit
Route Of Administration
Intramuscular , Intravenous
Schedule
SCHEDULE D
Ahfs
80:04.00
Atc Original
J06BB01 ANTI-D (RH) IMMUNOGLOBULIN
Aig Number
0106269004
Company Name
Aptevo BioTherapeutics LLC
Company Address
920 Cassatt Road, Suite 100 Berwyn Pennsylvania United States 19312
Company Detail Path
/organization/aptevo-biotherapeutics-llc
Company Information
Pharmaceutical Company Name
Aptevo BioTherapeutics LLC
Country Name
United States
Province Name
Washington
City Name
seattle,washington,country_us
Address
2401 4TH Ave Ste 1050
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
55eb2b1a8fe567a7
Type
Standard
Back to Health Canada Approvals